{"id":"https://openalex.org/W2892052275","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.5062","title":"Prevalence of homologous recombination deficiency (HRD) mutations in localized prostate cancer according to Gleason grade: Implications for neoadjuvant clinical trial design.","display_name":"Prevalence of homologous recombination deficiency (HRD) mutations in localized prostate cancer according to Gleason grade: Implications for neoadjuvant clinical trial design.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2892052275","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.5062","mag":"2892052275"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.5062","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.5062","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.5062","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072746498","display_name":"Catherine E. Handy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Handy","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062308537","display_name":"Alexander Spyridon Baras","orcid":"https://orcid.org/0000-0003-2397-3342","observed_orcids":["https://orcid.org/0000-0003-2397-3342"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander S Baras","raw_affiliation_strings":["The Johns Hopkins Medical Institutions, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Johns Hopkins Medical Institutions, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008552473","display_name":"Tamara Levin Lotan","orcid":"https://orcid.org/0000-0002-0494-9067","observed_orcids":["https://orcid.org/0000-0002-0494-9067"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tamara L. Lotan","raw_affiliation_strings":["Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018645768","display_name":"Emmanuel S. Antonarakis","orcid":"https://orcid.org/0000-0003-0031-9655","observed_orcids":["https://orcid.org/0000-0003-0031-9655","https://orcid.org/0000-0003-3531-3851"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emmanuel S. Antonarakis","raw_affiliation_strings":["Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"5062","last_page":"5062"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.3163999915122986,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.3163999915122986,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.28200000524520874,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.14839999377727509,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9739999771118164},{"id":"https://openalex.org/keywords/localized-prostate-cancer","display_name":"localized prostate cancer","score":0.9580000042915344},{"id":"https://openalex.org/keywords/gleason-grade","display_name":"Gleason grade","score":0.968999981880188},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.8889999985694885},{"id":"https://openalex.org/keywords/atm-mutations","display_name":"ATM mutations","score":0.9890000224113464},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.7239999771118164},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.8220000267028809},{"id":"https://openalex.org/keywords/biomarker-prevalence","display_name":"biomarker prevalence","score":0.4869999885559082},{"id":"https://openalex.org/keywords/dna-repair-genes","display_name":"DNA repair genes","score":0.45100000500679016},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.5989999771118164},{"id":"https://openalex.org/keywords/number-needed-to-screen","display_name":"number needed to screen","score":0.6570000052452087},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.6480000019073486},{"id":"https://openalex.org/keywords/fancd2","display_name":"FANCD2","score":0.5720000267028809},{"id":"https://openalex.org/keywords/chk1","display_name":"Chk1","score":0.5920000076293945}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7407417893409729},{"id":"https://openalex.org/C2778144015","wikidata":"https://www.wikidata.org/wiki/Q18046302","display_name":"PALB2","level":5,"score":0.6812105178833008},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6801002025604248},{"id":"https://openalex.org/C2778993383","wikidata":"https://www.wikidata.org/wiki/Q17927056","display_name":"FANCA","level":5,"score":0.5693628191947937},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4894672632217407},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4871827960014343},{"id":"https://openalex.org/C111425858","wikidata":"https://www.wikidata.org/wiki/Q14911708","display_name":"MLH1","level":5,"score":0.48594415187835693},{"id":"https://openalex.org/C2776071976","wikidata":"https://www.wikidata.org/wiki/Q14912280","display_name":"CHEK2","level":5,"score":0.4614706039428711},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4345552623271942},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.42094919085502625},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4025164246559143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3676624298095703},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3407503664493561},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33228564262390137},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.2690882682800293},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.26318788528442383},{"id":"https://openalex.org/C60748783","wikidata":"https://www.wikidata.org/wiki/Q2984243","display_name":"DNA mismatch repair","level":4,"score":0.15204182267189026},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.143798828125},{"id":"https://openalex.org/C2778124228","wikidata":"https://www.wikidata.org/wiki/Q845779","display_name":"Fanconi anemia","level":4,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.5062","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.5062","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.5062","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7200000286102295,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2889358404","https://openalex.org/W3168726630","https://openalex.org/W4408637448","https://openalex.org/W3122971575","https://openalex.org/W4409628473","https://openalex.org/W4379281921","https://openalex.org/W2983913506","https://openalex.org/W4396779608","https://openalex.org/W3007429920","https://openalex.org/W4417123734"],"abstract_inverted_index":{"5062":[0],"Background:":[1],"Approximately":[2],"5-10%":[3],"of":[4,49,140,168,202],"men":[5],"with":[6,63,128,271],"localized":[7,59,268],"prostate":[8,60,269],"cancer":[9],"have":[10,124],"homologous":[11],"recombination":[12],"deficiency":[13],"(HRD)":[14],"mutations,":[15],"yet":[16],"it":[17],"is":[18,52],"unknown":[19],"if":[20,46],"these":[21,122,287],"vary":[22],"by":[23,54,307],"Gleason":[24,55,69,152,272],"score.":[25],"In":[26],"order":[27],"to":[28,38,44,115,210,244],"help":[29],"design":[30],"neoadjuvant":[31,293],"trials":[32,297],"for":[33,135,151,179,292],"the":[34,40,47,89,112,125,166,230],"HRD+":[35,302],"population":[36],"and":[37,68,103,117,149,158,177,186,195,216,241,248,261,276,282],"minimize":[39],"number-needed-to-screen,":[41],"we":[42],"sought":[43],"determine":[45],"prevalence":[48,139,167,232,306],"HRD":[50,81,142,170,207,257,304,316],"mutations":[51,82,258,263],"influenced":[53],"grade.":[56],"Methods:":[57],"484":[58],"adenocarcinoma":[61],"cases":[62],"somatic":[64],"DNA":[65],"sequencing":[66],"data":[67],"grade":[70,309],"information":[71],"were":[72,83],"interrogated":[73],"using":[74,163,298],"The":[75,138],"Cancer":[76],"Genome":[77],"Atlas":[78],"(TCGA)":[79],"repository.":[80],"defined":[84],"as":[85],"pathogenic":[86],"lesions":[87],"in":[88,121,191,212,237,259,267,301],"following":[90],"genes:":[91],"ATM,":[92,118],"BRCA1/2,":[93],"CDK12,":[94],"CHEK1/2,":[95],"FANCA,":[96],"FANCD2,":[97],"FANCL,":[98],"GEN1,":[99],"NBN,":[100],"PALB2,":[101],"RAD51":[102],"RAD51C.":[104],"A":[105],"separate":[106],"analysis":[107],"was":[108,133,144,172,233],"also":[109],"conducted":[110],"restricting":[111],"gene":[113],"list":[114],"BRCA1/2":[116,226],"since":[119],"deficiencies":[120],"genes":[123],"strongest":[126],"association":[127],"PARP-inhibitor":[129],"response.":[130],"R":[131],"software":[132],"used":[134],"analyses.":[136],"Results:":[137],"(any)":[141,169],"mutation":[143,171,208,231,305,317,322],"11.6%,":[145,173],"10.8%,":[146],"14%,":[147],"16.8%":[148],"25.0%":[150],"sums":[153],"6,":[154],"7,":[155],"8,":[156],"9":[157,338],"10,":[159],"respectively.":[160],"When":[161,222],"analyzed":[162],"Grade":[164,180,192,213,238,245,273,311],"Groups,":[165],"6%,":[174],"17.8%,":[175],"14%":[176],"17%":[178],"Groups":[181,214,246],"1,":[182],"2,":[183],"3,":[184],"4":[185,281,351,357],"5,":[187],"respectively":[188],"(Table).":[189,255],"Those":[190],"Group":[193,239,274,312],"3":[194,240,275,343],"greater":[196],"had":[197],"2.5":[198],"times":[199,235],"higher":[200,236,277],"odds":[201],"harboring":[203],"at":[204],"least":[205,314,319],"one":[206],"compared":[209,243],"those":[211],"1":[215,247,315,320,327,333],"2":[217,249,335,341],"(16.8%":[218],"vs":[219,251],"7.3%,P=":[220],"0.002).":[221],"specifically":[223],"considering":[224],"only":[225],"or":[227],"ATM":[228],"lesions,":[229],"6.1":[234],"above":[242],"(8.9%":[250],"1.6%,":[252],"P=":[253],"0.0006)":[254],"Conclusions:":[256],"general,":[260],"BRCA1/2/ATM":[262,321],"specifically,":[264],"are":[265],"enriched":[266],"cancers":[270],"(i.e.":[278],"primary":[279],"pattern":[280],"higher).":[283],"We":[284],"propose":[285],"that":[286],"patients":[288],"could":[289],"be":[290],"targeted":[291],"(or":[294],"adjuvant)":[295],"clinical":[296],"PARP":[299],"inhibitors":[300],"populations.":[303],"gleason":[308],"group.":[310],"At":[313,318],"N":[323,325],"Total":[324,326],"11.6":[328],"%":[329,337,345,353,361],"5":[330,359],"43":[331,334],"2.3%":[332],"6.0":[336],"149":[339,342],"1.3%":[340],"17.8":[344],"18":[346],"101":[347,350],"10.9%":[348],"11":[349,365],"14.0":[352],"7":[354],"50":[355,358],"8.0%":[356],"17.0":[360],"24":[362],"141":[363,366],"7.8%":[364]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":2}],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2018-09-27T00:00:00"}